Attovia Therapeutics, Inc.(ATTO)

Biotechnology · San Carlos, CA

$18.00+0.82 (+4.80%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T12:45:30.448Z.

Stored calculation inputs

Calculation as of: 2026-10-06T12:45:30.448Z.

Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: N/A
Quote price: 17.995

FMP input reference: a5b8a39003d923715743cc0d1a2c59dcf36f227505f31b08d3d275f4059bcabd

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

ATTO Earnings Yield Metrics

EARNINGS YIELD

N/A

ATTO Competitors' Earnings Yield

ATTO

Attovia Therapeutics, Inc.

Current

Market Cap

$774.32M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DSGN

Design Therapeutics, Inc.

vs ATTO

Market Cap

$775.72M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GERN

Geron Corporation

vs ATTO

Market Cap

$776.24M

Earnings Yield

N/A

TTM Avg

0.17%

3Y Avg

0.17%

5Y Avg

0.17%

AHCO

AdaptHealth Corp.

vs ATTO

Market Cap

$780.95M

Earnings Yield

N/A

TTM Avg

5.97%

3Y Avg

4.36%

5Y Avg

4.36%

AVTX

Avalo Therapeutics, Inc.

vs ATTO

Market Cap

$767.46M

Earnings Yield

N/A

TTM Avg

0.35%

3Y Avg

0.35%

5Y Avg

0.35%

CTKB

Cytek Biosciences, Inc.

vs ATTO

Market Cap

$786.48M

Earnings Yield

N/A

TTM Avg

0.13%

3Y Avg

0.36%

5Y Avg

0.36%

CADL

Candel Therapeutics, Inc.

vs ATTO

Market Cap

$749.55M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AVR

Anteris Technologies Global Corp.

vs ATTO

Market Cap

$734.10M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GYRE

Gyre Therapeutics, Inc.

vs ATTO

Market Cap

$819.44M

Earnings Yield

N/A

TTM Avg

0.49%

3Y Avg

4.33%

5Y Avg

4.33%

ACHV

Achieve Life Sciences, Inc.

vs ATTO

Market Cap

$719.64M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Attovia Therapeutics, Inc. (ATTO)	$774.32M	N/A	N/A	N/A	N/A
Design Therapeutics, Inc. (DSGN)vs ›	$775.72M	N/A	N/A	N/A	N/A
Geron Corporation (GERN)vs ›	$776.24M	N/A	0.17%	0.17%	0.17%
AdaptHealth Corp. (AHCO)vs ›	$780.95M	N/A	5.97%	4.36%	4.36%
Avalo Therapeutics, Inc. (AVTX)vs ›	$767.46M	N/A	0.35%	0.35%	0.35%
Cytek Biosciences, Inc. (CTKB)vs ›	$786.48M	N/A	0.13%	0.36%	0.36%
Candel Therapeutics, Inc. (CADL)vs ›	$749.55M	N/A	N/A	N/A	N/A
Anteris Technologies Global Corp. (AVR)vs ›	$734.10M	N/A	N/A	N/A	N/A
Gyre Therapeutics, Inc. (GYRE)vs ›	$819.44M	N/A	0.49%	4.33%	4.33%
Achieve Life Sciences, Inc. (ACHV)vs ›	$719.64M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Earnings Yield: N/A

ATTO Earnings Yield Metrics

ATTO Competitors' Earnings Yield

Earnings Yield vs P/E Ratio

Earnings Yield Formula & Definition

Related Metrics